Dickinson L - Search Results

1

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

FitzGerald R, Dickinson L, Else L, Fletcher T, Hale C, Amara A, Walker L, Penchala SD, Lyon R, Shaw V, Greenhalf W, Bullock K, Lavelle-Langham L, Reynolds H, Painter W, Holman W, Ewings S, Griffiths G, Khoo S. FitzGerald R, et al. Among authors: dickinson l. Clin Infect Dis. 2022 Aug 24;75(1):e525-e528. doi: 10.1093/cid/ciac199. Clin Infect Dis. 2022. PMID: 35271729 Free PMC article. Clinical Trial.

2

Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.

Dickinson L, Back D, Pozniak A, Khoo S, Boffito M. Dickinson L, et al. Ther Drug Monit. 2007 Jun;29(3):361-7. doi: 10.1097/FTD.0b013e3180683b25. Ther Drug Monit. 2007. PMID: 17529895

3

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.

Dickinson L, Boffito M, Back DJ, Khoo SH, Pozniak AL, Mugyenyi P, Merry C, Autar RS, Burger DM, Aarons LJ. Dickinson L, et al. J Antimicrob Chemother. 2008 Dec;62(6):1344-55. doi: 10.1093/jac/dkn399. Epub 2008 Sep 29. J Antimicrob Chemother. 2008. PMID: 18824460 Free PMC article. Clinical Trial.

4

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.

Dickinson L, Boffito M, Back D, Waters L, Else L, Davies G, Khoo S, Pozniak A, Aarons L. Dickinson L, et al. J Antimicrob Chemother. 2009 Jun;63(6):1233-43. doi: 10.1093/jac/dkp102. Epub 2009 Mar 28. J Antimicrob Chemother. 2009. PMID: 19329800 Free PMC article.

5

Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons.

Dickinson L, Khoo S, Back D. Dickinson L, et al. Curr Opin HIV AIDS. 2008 May;3(3):296-305. doi: 10.1097/COH.0b013e3282f82bf1. Curr Opin HIV AIDS. 2008. PMID: 19372982

6

Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.

Dickinson L, Khoo S, Back D. Dickinson L, et al. Antiviral Res. 2010 Jan;85(1):176-89. doi: 10.1016/j.antiviral.2009.07.017. Epub 2009 Aug 7. Antiviral Res. 2010. PMID: 19665485 Review.

7

Pharmacokinetic evaluation of etravirine.

Dickinson L, Khoo S, Back D. Dickinson L, et al. Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1575-85. doi: 10.1517/17425255.2010.535811. Expert Opin Drug Metab Toxicol. 2010. PMID: 21077784 Review.

8

Grapefruit-drug interactions.

Seden K, Dickinson L, Khoo S, Back D. Seden K, et al. Among authors: dickinson l. Drugs. 2010 Dec 24;70(18):2373-407. doi: 10.2165/11585250-000000000-00000. Drugs. 2010. PMID: 21142260 Review.

9

Sequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategies.

Dickinson L, Boffito M, Back D, Else L, von Hentig N, Davies G, Khoo S, Pozniak A, Moyle G, Aarons L. Dickinson L, et al. Antimicrob Agents Chemother. 2011 Jun;55(6):2775-82. doi: 10.1128/AAC.00887-10. Epub 2011 Mar 21. Antimicrob Agents Chemother. 2011. PMID: 21422211 Free PMC article.

10

Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.

Else LJ, Douglas M, Dickinson L, Back DJ, Khoo SH, Taylor GP. Else LJ, et al. Among authors: dickinson l. Antimicrob Agents Chemother. 2012 Feb;56(2):816-24. doi: 10.1128/AAC.05186-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106215 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page